CMBA
NEO icon

C.M. Bidwell & Associates’s NeoGenomics NEO Stock Holding History

C.M. Bidwell & Associates’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-212
Closed -$3.33K – 517
2024
Q1 		$3.33K Buy
+212
New +$3.27K ﹤0.01% 380
2020
Q2 		– Sell
-1,075
Closed -$30K – 443
2020
Q1 		$30K Buy
+1,075
New +$32.2K 0.03% 224

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

C.M. Bidwell & Associates's NEO Position: Q2 2024 in Review

C.M. Bidwell & Associates sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 212 shares — an estimated $3.33K sold.

C.M. Bidwell & Associates first reported a position in NEO in Q1 2020 and held it in 2 quarters. The position peaked at $30K in Q1 2020. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • C.M. Bidwell & Associates reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 212 NeoGenomics shares in Q2 2024, an estimated $3.33K.
  • C.M. Bidwell & Associates first reported a position in NeoGenomics in Q1 2020 and held it in 2 quarters.
  • C.M. Bidwell & Associates's NeoGenomics position peaked at $30K in Q1 2020.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.